PT-141 (Bremelanotide)
Melanocortin agonist. FDA-approved as Vyleesi for female sexual dysfunction. Used off-label for libido in both sexes.
PT-141 (FDA-approved as Vyleesi) is the libido peptide. Different mechanism than Viagra — it works on desire, not just blood flow. Used as-needed, not daily. Nausea is the main side effect, especially the first few times.
FDA-approved drug. Most federations would not consider it disqualifying for libido use, but each federation has its own rules.
Approved as Vyleesi (Bremelanotide), 2019, for hypoactive sexual desire disorder in premenopausal women.
Yes — Vyleesi prescribed by gynecology, primary care, sexual-medicine providers.
Who it's for
- →Users with situational or low-baseline libido
- →Couples wanting a non-PDE5-inhibitor option
- →People for whom Viagra/Cialis don't address the desire side
What to expect
- Week 1
Effect within hours of first dose. Nausea common at first.
- Week 4
Tolerance to nausea builds. Effect remains.
- Week 8
Used episodically rather than continuously.
Dosing protocol
1.0-1.75 mg sub-q, 30-45 min before activity. No more than 1 dose in 24h, no more than 8 doses per month.
Stacks well with
Side effects
When NOT to use
- ⚠Uncontrolled hypertension
- ⚠Cardiovascular disease
- ⚠Personal history of melanoma
Bloodwork to monitor
- • Blood pressure baseline if using regularly
Common mistakes
- • Dosing too high on first use (nausea will dominate the experience)
- • Using daily instead of as-needed
- • Pairing with alcohol — amplifies nausea
Educational only. User-specific dosing is between you and a qualified provider.